We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-0.1%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$7.4B
AUM Growth
+$513M
Cap. Flow
+$604M
Cap. Flow %
8.16%
Top 10 Hldgs %
12.45%
Holding
1,816
New
83
Increased
1,274
Reduced
371
Closed
71

Top Buys

Rank Stock Value
1
SNN icon
Smith & Nephew
SNN
+$18.5M
2
PUK icon
Prudential
PUK
+$14.8M
3
DEO icon
Diageo
DEO
+$12.8M
4
AAPL icon
Apple
AAPL
+$10.3M
5
PG icon
Procter & Gamble
PG
+$9.59M

Sector Composition

Rank Sector Weight
1 Financials 16.89%
2 Technology 14.22%
3 Healthcare 14.03%
4 Energy 8.9%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$178M 2.41%
7,076,728
+417,788
+6% +$10.3M
XOM icon
2
ExxonMobil
XOM
$650B
$109M 1.48%
1,163,404
+57,072
+5% +$5.68M
JNJ icon
3
Johnson & Johnson
JNJ
$640B
$108M 1.46%
1,016,736
+87,794
+9% +$9.11M
MSFT icon
4
Microsoft
MSFT
$2.9T
$105M 1.41%
2,257,378
+180,119
+9% +$8.03M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.11T
$87.4M 1.18%
3,008,537
+210,416
+8% +$6.08M
PG icon
6
Procter & Gamble
PG
$340B
$76.5M 1.03%
913,115
+117,046
+15% +$9.59M
WFC icon
7
Wells Fargo
WFC
$254B
$67.1M 0.91%
1,293,587
+100,717
+8% +$5.18M
CVX icon
8
Chevron
CVX
$382B
$65.8M 0.89%
551,269
+43,443
+9% +$5.54M
NVS icon
9
Novartis
NVS
$302B
$63.1M 0.85%
747,610
+58,689
+9% +$4.75M
PFE icon
10
Pfizer
PFE
$143B
$60.6M 0.82%
2,160,950
+218,620
+11% +$6.14M
IBM icon
11
IBM
IBM
$213B
$59.9M 0.81%
329,886
+34,088
+12% +$6.21M
GE icon
12
GE Aerospace
GE
$364B
$57.7M 0.78%
470,165
+14,909
+3% +$1.86M
MRK icon
13
Merck
MRK
$322B
$53.7M 0.73%
948,630
+78,093
+9% +$4.39M
WMT icon
14
Walmart Inc
WMT
$909B
$53M 0.72%
2,077,470
+118,494
+6% +$2.99M
RDS.A
15
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$51.5M 0.7%
677,003
+62,694
+10% +$5.03M
PEP icon
16
PepsiCo
PEP
$196B
$51.4M 0.7%
552,449
+49,084
+10% +$4.48M
JPM icon
17
JPMorgan Chase
JPM
$916B
$50.6M 0.68%
839,958
+70,459
+9% +$4.12M
INTC icon
18
Intel
INTC
$413B
$49.5M 0.67%
1,422,834
+115,345
+9% +$3.91M
KO icon
19
Coca-Cola
KO
$383B
$46.4M 0.63%
1,088,794
+94,843
+10% +$3.92M
DIS icon
20
Walt Disney
DIS
$171B
$46.3M 0.63%
520,547
+40,691
+8% +$3.59M
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.1T
$44.4M 0.6%
321,060
+22,994
+8% +$3.06M
CVS icon
22
CVS Health
CVS
$135B
$43.3M 0.58%
543,621
+57,549
+12% +$4.54M
GILD icon
23
Gilead Sciences
GILD
$165B
$42.9M 0.58%
403,142
+37,709
+10% +$3.69M
BAC icon
24
Bank of America
BAC
$429B
$42.8M 0.58%
2,511,504
+195,352
+8% +$3.11M
T icon
25
AT&T
T
$164B
$42.2M 0.57%
1,584,999
+109,578
+7% +$2.92M

Similar funds

Aperio Group's Q3 2014 Portfolio in Review

As of Q3 2014, Aperio Group held 1,816 positions worth $7.4B, up 7.4% from $6.89B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $604M of net new capital in Q3 2014, opening 83 new positions and adding to 1,274 existing holdings. Its largest new stake was Prudential: 326,014 shares worth $14.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was GSK, an estimated $4.47M trimmed.

  • Aperio Group's largest Q3 2014 buy was Prudential: 326,014 shares worth $14.1M.
  • Aperio Group added most to Smith & Nephew in Q3 2014, an estimated $18.5M increase.
  • Aperio Group's biggest Q3 2014 reduction was GSK, cutting an estimated $4.47M.
  • Aperio Group fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q3 2014, selling an estimated $16.5M.
  • Aperio Group's ten largest holdings make up 12% of its $7.4B portfolio in Q3 2014.
  • Aperio Group opened 83 new positions and closed 71 in Q3 2014.
  • Aperio Group's portfolio value rose 7.4% quarter-over-quarter to $7.4B.

Based on Aperio Group's 13F filing for Q3 2014, filed 21 Oct 2014.